Drugs News and Research

RSS

Recommendations on new cancer drug review process fall short in several ways: CCAC

While the Colorectal Cancer Association of Canada congratulates Quebec Health Minister Yves Bolduc on the recommendations of the report of the Working Group on the evaluation process of new anti cancer medications (Rapport du Groupe de travail sur le processus d'évaluation des médicaments anticancéreux) recently issued, the CCAC notes that the recommendations fall short in several important ways.

4 Jun 2011

International drug policy panel calls for legalization of some drugs, de-criminalizing drug use

The Global Commission on Drug Policy - a panel that includes former U.N. Secretary-General Kofi Annan, Global Fund to Fight AIDS, Tuberculosis and Malaria Executive Director Michel Kazatchkine, and several other current and former world leaders - has released a report calling for "the legalization of some types of drugs and an end to the criminalization of drug users," The Voice of Russia reports.

4 Jun 2011

Researchers develop new technology to detect neurological symptoms associated with epileptic seizure

Tiny electrodes have been coated with a drug-loaded polymer in an attempt to design an implant capable of detecting a number of neurological symptoms, such as those associated with an epileptic seizure, and treating them simultaneously.

4 Jun 2011

Researcher to evaluate new approach for treatment of triple-negative breast cancer

A multicenter clinical trial led by a researcher at the University of Maryland Marlene and Stewart Greenebaum Cancer Center will evaluate a new approach to treat triple-negative breast cancer, an often-aggressive type of cancer that is more common among African-Americans and young women.

4 Jun 2011

Budget cuts should not include U.S. global AIDS program

"Now is not the time for the United States - or any other country - to reduce spending on programs that deliver life-saving drugs at so tiny a cost," a Des Moines Register editorial states, noting the relatively small cost of PEPFAR.

4 Jun 2011

From the legislatures: Calif. Assembly passes rate regulation bill; Wis. lawmakers vote to raise health costs for new firefighters, police

The state Assembly approved a bill Thursday that would give state regulators the power to reject or modify excessive health insurance premium increases similar to the way auto and homeowner insurance is regulated in California. Lawmakers voted 47-28 to approve the measure after Republican legislators walked off the floor in protest. AB52 now moves to the state Senate.

4 Jun 2011

Nano-formulated indomethacin at lower dose effective in treating pain

A novel, lower-dose formulation of indomethacin, a widely used pain reliever, is absorbed faster by the body than a standard formulation and maintains comparable maximum concentrations in the blood despite being administered at a lower dose, according to a study to be reported here tomorrow at the annual meeting of the American Headache Society.

4 Jun 2011

Money must be spent wisely in fight against HIV/AIDS, report says

"More money, less waste and smarter programmes are urgently needed to consolidate precious gains in the war on AIDS and HIV, UNAIDS said" in a report released on Thursday ahead of the disease's 30th anniversary and the beginning of the U.N. High Level Meeting on AIDS, Agence France-Presse reports.

4 Jun 2011

UCLA pediatric investigators earn top accolades at TTCF Faculty Presentation Awards

A new therapy for type 1 diabetes? A promising treatment for deadly viruses? Does a common treatment for children with severe infection actually cause more harm than good? These are important questions being investigated by pediatric researchers at Mattel Children's Hospital UCLA.

4 Jun 2011

Decreasing iron-storing protein expression can enhance action of brain cancer therapy: Researchers

Brain cancer therapy may be more effective if the expression of an iron-storing protein is decreased to enhance the action of therapeutic drugs on brain cancer cells, according to Penn State College of Medicine researchers.

4 Jun 2011

Scientists identify chromosomal mutation responsible for excessive hair growth

Researchers in the Keck School of Medicine of the University of Southern California (USC), together with scientists in Beijing, China, have discovered a chromosomal mutation responsible for a very rare condition in which people grow excess hair all over their bodies.

4 Jun 2011

Medical oncologists confirm benefits of crizotinib in ALK positive lung cancer

A drug that targets a specific type of lung cancer shows a dramatic response in more than half of the people who take it. The drug, called crizotinib, has been in clinical trials since 2006, and the results from the largest group of patients to take it within the first of these clinical trials are being presented at the annual meeting of the American Society of Clinical Oncology.

4 Jun 2011

Ipilimumab and bevacizumab drugs effective in treating metatastic melanoma

A duo of drugs, each targeting a prime survival strategy of tumors, can be safely administered and are potentially more effective than either drug alone for advanced, inoperable melanomas, according to a phase 1 clinical trial led by Dana-Farber Cancer Institute investigators.

4 Jun 2011

Cancer vaccine shows improved response rate in patients

A vaccine for one of the most lethal cancers, advanced melanoma, has improved response rate and progression-free survival for patients when combined with the immunotherapy drug Interleukin-2, according to research led by scientists from The University of Texas MD Anderson Cancer Center and Indiana University Health Goshen Center for Cancer Care.

3 Jun 2011

Bexarotene and erlotinib drugs effective in treating advanced lung cancer

Scientists have identified a drug combination, when used in advanced lung cancer patients, shows a survival advantage in patients who no longer respond to existing therapies.

3 Jun 2011

Preclinical study: Combination therapy of SPX-106 and D-tagatose reduces triglycerides and cholesterol

Spherix Incorporated, an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that its drug candidate, SPX-106, achieved statistically significant reductions in triglycerides and cholesterol when administered in combination with D-tagatose for nine weeks to genetically engineered mice prone to dyslipidemia.

3 Jun 2011

New survey: State tax revenues up but so are Medicaid costs

Although state tax collections are picking up after several brutal years, a new survey by the National Governors Association and the National Association of State Budget Officers found that states still expect to collect less tax revenue and spend less money in the coming fiscal year than they did before the Great Recession began.

3 Jun 2011

Medical researchers uncover a novel approach to treat Huntington's disease

Medical researchers may have uncovered a novel approach to treat an incurable and ultimately fatal neurodegenerative disease that affects hundreds of thousands of people.

3 Jun 2011

Majority of patients with ulcerative colitis eager to undergo fecal microbiota transplantation

The first study of the social and ethical issues associated with a provocative approach to treatment for ulcerative colitis has found that the majority of potential patients are eager for what is now called "fecal microbiota transplantation" to become available, although many have concerns about donor selection, screening, and methods of delivery.

3 Jun 2011

Insight into beneficial epilepsy treatments for children with autism

Physicians will have a better guide for more effectively managing treatment of children experiencing seizures related to autism with the results of a study by researchers at Arizona State University and the University of Texas-Houston.

3 Jun 2011

Drugs News and Research

Recommendations on new cancer drug review process fall short in several ways: CCAC

International drug policy panel calls for legalization of some drugs, de-criminalizing drug use

Researchers develop new technology to detect neurological symptoms associated with epileptic seizure

Researcher to evaluate new approach for treatment of triple-negative breast cancer

Budget cuts should not include U.S. global AIDS program

From the legislatures: Calif. Assembly passes rate regulation bill; Wis. lawmakers vote to raise health costs for new firefighters, police

Nano-formulated indomethacin at lower dose effective in treating pain

Money must be spent wisely in fight against HIV/AIDS, report says

UCLA pediatric investigators earn top accolades at TTCF Faculty Presentation Awards

Decreasing iron-storing protein expression can enhance action of brain cancer therapy: Researchers

Scientists identify chromosomal mutation responsible for excessive hair growth

Medical oncologists confirm benefits of crizotinib in ALK positive lung cancer

Ipilimumab and bevacizumab drugs effective in treating metatastic melanoma

Cancer vaccine shows improved response rate in patients

Bexarotene and erlotinib drugs effective in treating advanced lung cancer

Preclinical study: Combination therapy of SPX-106 and D-tagatose reduces triglycerides and cholesterol

New survey: State tax revenues up but so are Medicaid costs

Medical researchers uncover a novel approach to treat Huntington's disease

Majority of patients with ulcerative colitis eager to undergo fecal microbiota transplantation

Insight into beneficial epilepsy treatments for children with autism

Drug Discovery - Second Edition eBook

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News